CATHETER PRECISION INC
VTAKNYSE AMERICANTrading Snapshot
- Day Range
- $0.14 – $0.15
- 52-Week Range
- $0.13 – $3.20
- Volume
- $3.62B
- Avg Volume
- $3.66B
- Shares Outstanding
- 2.7M
- Next Earnings
- Dec 7, 2026
Fundamentals Snapshot
- Annual Revenue
- $819,000
- Last Q Revenue
- $1M
- P/E Ratio
- -0.0
- P/S Ratio
- 0.2x
- EPS (TTM)
- $-0.00
- Dividend Yield
- 0.00%
- Dilution (1yr)
- +13399.9%
Why Investors Own VTAK
- ✓High-growth profile — revenue up -9.6% YoY with expanding US Equity exposure.
- ✓Healthy economics — 26% gross margin and 30% free-cash-flow margin.
- ✓New products and segments could unlock additional revenue streams.
Execution delays, intensifying competition, and valuation compression if growth decelerates.
CATHETER PRECISION INC
VTAK
StockOtter · stockotter.spaceAbout CATHETER PRECISION INC
Catheter Precision, Inc., headquartered in Fort Mill, South Carolina, is dedicated to creating and distributing electrophysiology products. Their mission is to enhance treatment and outcomes for U.S. patients suffering from cardiac arrhythmias by providing innovative technologies and solutions to patients, hospitals, and physicians. Their premier product, the View into Ventricular Onset System (VIVO), is a non-invasive 3D cardiac mapping solution designed to accurately locate the origin points of idiopathic ventricular arrhythmias in patients with otherwise healthy hearts, before they undergo electrophysiology procedures. Additionally, they offer LockeT, a device for suture retention, and the Amigo Remote Catheter System, a robotic arm used for precise catheter control. The company, previously known as Ra Medical Systems, Inc., officially adopted the name Catheter Precision, Inc. in August 2023.
Otter Score Breakdown
How it's scoredFive components, each rated 1–5★ and equally weighted (20%), averaged to a 0–100 score:💎 Quality — gross margin🚀 Growth — revenue YoY⚖️ Valuation — P/S ratio⚡ Momentum — 30-day price change💧 Dilution — 1-yr share issuance (buybacks score higher)Analyst Price Target
ⓘLatest News & Updates
Catheter Precision Expands LockeT Commercialization Across Latin America Following Successful Launch in Brazil
LockeT Has Expanded to Six Hospitals in Brazil Since Its August Launch Company Engages Experienced Cardiology Group to Support Expansion Across Argentina, Chile, Colombia and Additional Latin American Markets FORT MILL,
Flyte Partners With Christian Cowan for New York Fashion Week, Expanding Its Presence Across Global Luxury Brands
Strategic Partnership Positions Flyte at the Intersection of Private Aviation, Fashion, and Entertainment Collaboration Introduces Flyte to a High-Value Audience of Celebrities, Executives, Creators and Cultural Tastemak
Flyte Secures International Approval to Launch Private Aviation Service Across The Bahamas and Caribbean
Landmark international milestone unlocks significant new markets and broadens Flyte's addressable aviation footprint beyond the United States New capabilities connect Flyte's growing Florida network with high-demand leis
Catheter Precision Achieves Major Commercial Milestones with Cardinal Health, Johns Hopkins and the placement of the First VIVO System in Germany
Received First LockeT Purchase Order Through Cardinal Health which serves approximately 90% of U.S. Hospitals though its Medical Products business
Flyte Surpasses 10,000 Consumer Accounts as WebApp Growth Accelerates
New Account Creation Increased 170% During the First 17 Days of August Compared to the Same Period in July Flyte Has Added More Accounts Since July 1 Than During the Entire First Half of 2026 Growing First-Party Customer
Flyte Partners with FullPAC to Bring Regional Aviation to the $11.4 Billion U.S. Political Campaign Market
Strategic Partnership Positions Flyte as the Premier Regional Aviation Solution for Statewide Campaigns While Expanding Access to More Than 5,000 Candidates, SuperPACs and Political Organizations